Our Collaborators on the Lentiviral Project
DNAVEC are a small biotech company based in Tsukuba, Japan. They have a number of product platforms based around the Sendai Virus vector and now the Lentivirus.
In addition to working with the consortium on CF they have interests in cardiovascular disease, ophthalmologic conditions, cancer and Alzheimer's Disease.
Site map
Information for Patients on Our Clinical Trial
Consortium Members' Internal Website
Our Research
Cystic Fibrosis
Publications
Medical Futures Innovation Award 2011